[ad_1]
VACCINAS developer Pfizer Inc. has submitted an emergency use authorization (US) request to the Food and Drug Administration (FDA) for its 2019 coronavirus disease (Covid-19) vaccine, Malacañang announced on Saturday.
Citing FDA CEO Rolando Domingo, Palace spokesman Harry Roque Jr. confirmed that Pfizer applied for USA on December 23.
“The FDA will take 21 days to evaluate and approve the EUA, but vaccination will begin as soon as stocks are available,” Roque said in a statement.
In addition to Pfizer, vaccine czar Carlito Galvez Jr. has said the government was also in talks with six other vaccine companies including Novavax, Johnson & Johnson, Moderna, Sinovac, Gamaleya and SinoPharm.
Gálvez said that they are already in the advanced stage of negotiations with five of these companies, including Pfizer.
Pfizer’s vaccine is already in use in the United States and the United Kingdom, while Moderna has just received an EUA from Washington.
The Philippine government intends to inoculate around 24.7 million Filipinos in the first part of the Covid-19 vaccination program.
Some 1.76 million healthcare workers rank first on the list of priority beneficiaries of the Covid-19 vaccination. Front-line doctors will be followed by elderly, homeless Filipinos and uniformed personnel.
[ad_2]
